文献詳細
特集 朝まで待てない! 夜間頻尿完全マスター
〈夜間頻尿の治療〉
文献概要
▶ポイント
・デスモプレシンは,夜間多尿の薬物療法のなかで推奨グレードAと判定された唯一の薬剤である.
・デスモプレシンは,男性にのみ保険が適用されている.
・デスモプレシンは適正な飲水管理の下で,低Na血症を防止しながら奏効する.
・デスモプレシンは,夜間多尿の薬物療法のなかで推奨グレードAと判定された唯一の薬剤である.
・デスモプレシンは,男性にのみ保険が適用されている.
・デスモプレシンは適正な飲水管理の下で,低Na血症を防止しながら奏効する.
参考文献
1) Bosch JL, et al : The Prevalence and Causes of Nocturia. J Urol 189 (1 Suppl) : S86-92, 2013
2) Weiss JP, et al : Excessive Nocturnal Urine Production Is a Major Contributing Factor to the Etiology of Nocturia. J Urol 186 : 1358-1363, 2011
3) van Kerrebroeck P, et al : The Standardisation of Terminology in Nocturia : Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21 : 179-183, 2002
4) 日本排尿機能学会, 他 (編) : 夜間頻尿診療ガイドライン [第2版]. リッチヒルメディカル, 東京, 2020
5) Nielsen S, et al : Aquaporins in the Kidney : From Molecules to Medicine. Physiol Rev 82 : 205-244, 2002
OD錠50 μg. 添付文書. 2020年10月 (第4版)
7) Yamaguchi O, et al : Efficacy and Safety of 25 and 50 μg Desmopressin Orally Disintegrating Tablets in Japanese Patients with Nocturia Due to Nocturnal Polyuria : Results from Two Phase 3 Studies of a Multicenter Randomized Double-Blind Placebo-Controlled Parallel-Group Development Program. Low Urin Tract Symptoms 12 : 8-19, 2020
8) Stanley N : The Physiology of Sleep and the Impact of Ageing. Eur Urol Suppl 3 : 17-23, 2005
9) Lentz MJ, et al : Effects of Selective Slow Wave Sleep Disruption on Musculoskeletal Pain and Fatigue in Middle Aged Women. J Rheumatol 26 : 1586-1592, 1999
10) Weiss JP, et al : Desmopressin Orally Disintegrating Tablet Effectively Reduces Nocturia : Results of a Randomized, Double-Blind, Placebo-Controlled Trial. Neurourol Urodyn 31 : 441-447, 2012
11) 日本排尿機能学会 (編) : 夜間頻尿診療ガイドライン. ブラックウェルパブリッシング, 東京, 2009
12) Reynard JM, et al : A Novel Therapy for Nocturnal Polyuria : A Double-Blind Randomized Trial of Frusemide Against Placebo. Br J Urol 81 : 215-218, 1998
13) Cho MC, et al : Alpha-Blocker Plus Diuretic Combination Therapy as Second-Line Treatment for Nocturia in Men with LUTS : A Pilot Study. Urology 73 : 549-555, 2009
14) Addla SK, et al : Diclofenac for Treatment of Nocturia Caused by Nocturnal Polyuria : A Prospective, Randomised, Double-Blind, Placebo-Controlled Crossover Study. Eur Urol 49 : 720-725, 2006
15) Falahatkar S, et al : Celecoxib for Treatment of Nocturia Caused by Benign Prostatic Hyperplasia : A Prospective, Randomized, Double-Blind, Placebo-Controlled Study. Urology 72 : 813-816, 2008
16)Hunsballe JM, et al : Single Dose Imipramine Reduces Nocturnal Urine Output in Patients with Nocturnal Enuresis and Nocturnal Polyuria. J Urol 158 : 830-836, 1997
17) Dani H, et al : Nocturia : Aetiology and Treatment in Adults. Nat Rev Urol 13 : 573-583, 2016
18) Yoshida M, et al : Effectiveness of Tamsulosin Hydrochloride and Its Mechanism in Improving Nocturia Associated with Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia. Neurourol Urodyn 29 : 1276-1281, 2010
19) Kojima Y, et al : Tamsulosin Reduces Nighttime Urine Production in Benign Prostatic Hyperplasia Patients with Nocturnal Polyuria : A Prospective Open-Label Long-Term Study Using Frequency-Volume Chart. Neurourol Urodyn 31 : 80-85, 2012
20) Yokoyama O, et al : Efficacy of Fesoterodine on Nocturia and Quality of Sleep in Asian Patients with Overactive Bladder. Urology 83 : 750-755, 2014
21) Yokoyama O, et al : Imidafenacin, an Antimuscarinic Agent, Improves Nocturia and Reduces Nocturnal Urine Volume. Urology 82 : 515-520, 2013
掲載誌情報